Research published in Journal watch - The Consciousness Library

Psilocybin for Depression

Journal watch November 6, 2020

Exploratory studies have examined the usefulness of the hallucinogen psilocybin for depressed cancer patients and patients with treatment-resistant

DOI: 10.1056/nejm-jw.na52780

MDMA-Facilitated Psychotherapy for Chronic PTSD: A Pilot Study

Journal watch May 18, 2018 Peter Roy‐Byrne

Current treatments for chronic post-traumatic stress disorder (PTSD) have limited efficacy. In a two-stage, phase 2 study (funded by a nonprofit

DOI: 10.1056/nejm-jw.na46715

Intranasal Esketamine Reduces Depression and Suicidality, Modestly and Briefly

Journal watch April 23, 2018 Joel Yager

Intravenous ketamine reduces symptoms of depression and suicidality for up to several weeks, but less is known about the non–FDA-approved intranasal

DOI: 10.1056/nejm-jw.na46536

Intranasal Esketamine for Treatment-Resistant Depression

Journal watch January 16, 2018 Peter Roy‐Byrne

With limited medication options for treatment-resistant depression, patients often turn to transcranial magnetic stimulation (TMS), electroconvulsive

DOI: 10.1056/nejm-jw.na45881

Can Psilocybin Treat Severe Depression

Journal watch November 3, 2017

In 1970, the FDA categorized psilocybin as a Schedule 1 drug, largely because of its recreational uses, which include inducing spirituality and

DOI: 10.1056/nejm-jw.na45292

It’s Not Benign: Cannabis, Cognition, and Psychosis

Journal watch December 28, 2007 Deborah Cowley

Despite persistent questions about causality and the confounding of results, this past year has seen the strongest evidence to date of an association

DOI: 10.1056/jp200712280000006

Cannabis, Cognition, and the Prefrontal Cortex

Journal watch June 11, 2007 Barbara Geller

Researchers have reported a possible association between cannabis use and adolescent onset of schizophrenia, and magnetic resonance spectroscopy (MRS)

DOI: 10.1056/jp200706110000004

Controlling Nightmares with Imagery Rehearsal Therapy

Journal watch 2001 Gilbert M. Tucker

Recurrent nightmares are common in patients with post-traumatic stress disorder (PTSD), but rarely are nightmares treated directly. These researchers randomized 168 women with chronic nightmares and DSM-IIIR-diagnosed PTSD to receive imagery rehearsal therapy (IRT) or to be placed on a wait list (control group). Of the participants, 79 percent were …

DOI: 10.1056/jp200109050000001

Risperidone May Be Contraindicated in Post-LSD Visual Disorder

Journal watch September 1, 1996 Peter Roy‐Byrne

Numerous reports have documented persistent visual disturbances (i.e., afterimages, light flashes, geometric pseudohallucinations, and image trails) in

DOI: 10.1056/jp199609010000012

Papers